Funding Opportunities
HEALTH & HUMAN SERVICES
NIH/CDC/FDA Omnibus
Due: April 5, 2021
SBIR Omnibus/Parent Clinical Trial Not Allowed Funding Opportunity Announcement
STTR Omnibus/Parent Clinical Trial
Not Allowed Funding Opportunity Announcement
SBIR Omnibus/Parent Clinical Trial
Required Funding Opportunity Announcement
STTR Omnibus/Parent Clinical Trial Required Funding Opportunity Announcement
Due: 4/5/2021.
The goals of these solicitations are to facilitate commercialization of products funded by SBIR/STTR Phase II or Phase IIB projects by providing further technical and/or later stage research development such as Investigational New Drug (IND)/Investigational Device Exemption (IDE) enabling studies, clinical studies, manufacturing costs and regulatory assistance. The funding opportunities can be found here.
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed)
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
NATIONAL SCIENCE FOUNDATION (NSF)
Submission windows for 2021:
Feb 12 to March 4
March 5 to June 3
June 4 to Sept 2
Sept 3 to Dec 2